1. Effects of an in situ instructional design based postpartum hemorrhage simulation training on patient outcomes: an uncontrolled before-and-after study
- Author
-
Arno M. M. Muijtjens, Cees P. M. van der Vleuten, Jeroen J. G. van Merriënboer, Leila Katz, Ana Rodrigues Falbo, Brena Carvalho Pinto de Melo, RS: SHE - R1 - Research (OvO), and Onderwijsontw & Onderwijsresearch
- Subjects
030219 obstetrics & reproductive medicine ,business.industry ,Instructional design ,instructional design guidelines ,Obstetrics and Gynecology ,medicine.disease ,simulation ,GUIDELINES ,Simulation training ,Obstetric care ,03 medical and health sciences ,0302 clinical medicine ,Obstetrics and gynaecology ,postpartum hemorrhage ,Pediatrics, Perinatology and Child Health ,SKILLS ,Medicine ,Before and after study ,030212 general & internal medicine ,Medical emergency ,business ,Instruction ,OBSTETRIC CARE ,patient outcome - Abstract
Objective: To compare postpartum hemorrhage (PPH) patient outcomes before and after an in situ instructional design based PPH simulation attended by obstetrics and gynecology (OBGYN) residents. Methods: This uncontrolled before-and-after study was conducted in Recife, Brazil including all 1388 women delivering from June to August 2012 and all 1357 delivering from June to August 2013. The 36 OBGYN residents were divided into13 teams of two or three participants and were trained through ID based PPH simulation training with the following eight steps: (1) prior knowledge activation, (2) video demonstration, (3) dual-coding PPH protocol discussion-an image association during the training, (4) training scenario # 1, (5) debriefing, (6) training scenario # 2 with immediate feedback, (7) training scenario # 3, and (8) debriefing with self-assessment. The training scenarios had an increasing level of complexity. The main goal of the training was the adequate management of PPH and situational awareness improvement-the ability to anticipate, recognize, and intercept unfolding error chains. The primary patient outcomes rates used for the before and after comparison were therapeutic uterotonics use within 24 h of birth and blood transfusion. Secondary outcomes were therapeutic oxytocin mean dosage IU within 24 h of birth, postpartum Hb
- Published
- 2021